Igomed - Company finances
|
EUR
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 12,621 | 8,565 | 12,682 | 13,272 | 14,937 | 14,482 | 13,653 |
| Profit before tax | 904 | -511 | 6,230 | 8,748 | 10,591 | 9,930 | 9,379 |
| Net profit | 459 | -735 | 5,773 | 8,311 | 10,061 | 9,446 | 8,832 |
| Equity | 4,507 | 3,772 | 9,545 | 8,856 | 12,917 | 16,363 | 18,195 |
| Liabilities | - | - | - | 703 | 792 | 744 | 667 |
| Non-current assets | 633 | 568 | 1,596 | 1,110 | 777 | 465 | 290 |
| Current assets | 4,335 | 3,596 | 8,631 | 8,449 | 12,932 | 16,852 | 18,572 |
| Total assets | 4,968 | 4,164 | 10,227 | 9,559 | 13,709 | 17,317 | 18,862 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 437 | 532 | 482 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | -32.1% | +48.1% | +4.7% | +12.5% | -3.0% | -5.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 9.2% | -17.7% | 56.4% | 86.9% | 73.4% | 54.5% | 46.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.2% | -19.5% | 60.5% | 93.8% | 77.9% | 57.7% | 48.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.6% | -8.6% | 45.5% | 62.6% | 67.4% | 65.2% | 64.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.2% | -6.0% | 49.1% | 65.9% | 70.9% | 68.6% | 68.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.1 | 0.1 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Igomed - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-12-23 | 2022-12-31 | 2221.33 |
Igomed - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Igomed, II, code 300557059, is an Individual Enterprise engaged in physiotherapy activities. In 2025, the company generated revenue of €13.7K, down 5.7% year on year and 8.6% over two years. Net profit remained solid at €8.8K, with a profit margin of 64.7%. The business has shown a gradual softening in top-line performance, with revenue moving from €14.9K in 2023 to €14.5K in 2024 and €13.7K in 2025, while net profit declined from €10.1K to €9.4K and then to €8.8K over the same period. Despite the lower turnover, profitability stayed high throughout the three-year period, with margins above 64%. The balance sheet remained conservative: total assets reached €18.9K in 2025, equity stood at €18.2K, and liabilities were only €667. Equity accounted for 96.5% of assets, with debt-to-equity at 0.04. Return on equity was 48.5% and return on assets 46.8%, while asset turnover was 0.72x.